Concepedia
Statistics
Publications
5
Citations
183
H-Index
Active since
2015
Affiliations
Karolinska Institutet(Current)
Uppsala University
Science for Life Laboratory
Angelos Heldin is an author at Karolinska Institutet specializing in oncology, life sciences, and molecular biology.
Publications per year
2015–2023
Tamoxifen Inhibits TGF‐β‐Mediated Activation of Myofibroblasts by Blocking Non‐Smad Signaling Through ERK1/2
Jon M. Carthy, Anders Sundqvist, Angelos Heldin et al. · Journal of Cellular Physiology · 2015 · 84 citations
Life Sciences, Molecular Biology, Molecular Medicine +11
Synergistic Rescue of Nonsense Mutant Tumor Suppressor p53 by Combination Treatment with Aminoglycosides and Mdm2 Inhibitors
Meiqiongzi Zhang, Angelos Heldin, Mireia Palomar-Siles et al. · Frontiers in Oncology · 2018 · 40 citations · Full text
Medicine, Oncology, Pharmacology +13
Translational readthrough of nonsense mutant TP53 by mRNA incorporation of 5-Fluorouridine
Mireia Palomar-Siles, Angelos Heldin, Meiqiongzi Zhang et al. · Cell Death and Disease · 2022 · 35 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
Chemical regulators of epithelial plasticity reveal a nuclear receptor pathway controlling myofibroblast differentiation
Jon M. Carthy, Martin Stöter, Claudia Bellomo et al. · Scientific Reports · 2016 · 12 citations · Full text
Life Sciences, Molecular Biology, Pharmacology +17
Novel compounds that synergize with aminoglycoside G418 or eRF3 degraders for translational readthrough of nonsense mutant <i>TP53</i> and <i>PTEN</i>
Angelos Heldin, Matko Čančer, Mireia Palomar-Siles et al. · RNA Biology · 2023 · 12 citations · Full text
1–5 of 5